High-quality full-length immunoglobulin profiling with unique molecular barcoding
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
27490633
DOI
10.1038/nprot.2016.093
PII: nprot.2016.093
Knihovny.cz E-zdroje
- MeSH
- lehké řetězce imunoglobulinů genetika MeSH
- lidé MeSH
- mutace MeSH
- myši MeSH
- řízení kvality MeSH
- sekvence nukleotidů MeSH
- sekvenční analýza DNA metody MeSH
- těžké řetězce imunoglobulinů genetika MeSH
- vysoce účinné nukleotidové sekvenování metody MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- lehké řetězce imunoglobulinů MeSH
- těžké řetězce imunoglobulinů MeSH
High-throughput sequencing analysis of hypermutating immunoglobulin (IG) repertoires remains a challenging task. Here we present a robust protocol for the full-length profiling of human and mouse IG repertoires. This protocol uses unique molecular identifiers (UMIs) introduced in the course of cDNA synthesis to control bottlenecks and to eliminate PCR and sequencing errors. Using asymmetric 400+100-nt paired-end Illumina sequencing and UMI-based assembly with the new version of the MIGEC software, the protocol allows up to 750-nt lengths to be sequenced in an almost error-free manner. This sequencing approach should also be applicable to various tasks beyond immune repertoire studies. In IG profiling, the achieved length of high-quality sequence covers the variable region of even the longest chains, along with the fragment of a constant region carrying information on the antibody isotype. The whole protocol, including preparation of cells and libraries, sequencing and data analysis, takes 5 to 6 d.
Center of Molecular Medicine CEITEC Masaryk University Brno Czech Republic
Pirogov Russian National Research Medical University Moscow Russia
Shemiakin Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Science Moscow Russia
Zobrazit více v PubMed
Oncotarget. 2012 Apr;3(4):502-13 PubMed
Curr Protoc Immunol. 2006 Dec;Chapter 7:Unit 7.5 PubMed
Blood. 2011 Jul 14;118(2):348-57 PubMed
Nat Methods. 2011 Nov 20;9(1):72-4 PubMed
Curr Protoc Stem Cell Biol. 2007 Jun;Chapter 2:Unit 2A.1 PubMed
Nat Methods. 2015 May;12(5):380-1 PubMed
PLoS One. 2015 Mar 05;10(3):e0119123 PubMed
Nat Immunol. 2015 Jun;16(6):663-73 PubMed
Nucleic Acids Res. 1999 Mar 15;27(6):1558-60 PubMed
Genes Immun. 2012 Sep;13(6):469-73 PubMed
Sci Transl Med. 2013 Feb 6;5(171):171ra19 PubMed
Science. 2009 May 8;324(5928):807-10 PubMed
J Immunol. 2015 Jun 15;194(12):6155-63 PubMed
PLoS One. 2012;7(5):e36750 PubMed
Cell Host Microbe. 2013 Jun 12;13(6):691-700 PubMed
J Clin Lab Anal. 2002;16(1):47-51 PubMed
Sci Adv. 2016 Mar 11;2(3):e1501371 PubMed
PLoS One. 2013 Jul 23;8(7):e70388 PubMed
Immunol Cell Biol. 2015 Nov;93(10):885-95 PubMed
J Immunol. 2014 Jan 15;192(2):603-11 PubMed
Genome Res. 2009 Oct;19(10):1817-24 PubMed
Sci Rep. 2014 Oct 27;4:6778 PubMed
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2622-9 PubMed
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4928-33 PubMed
Ann Rheum Dis. 2014 Apr;73(4):756-62 PubMed
BMC Genomics. 2011 Feb 11;12:106 PubMed
Front Immunol. 2014 Jun 02;5:250 PubMed
Nature. 2008 May 29;453(7195):667-71 PubMed
Am J Clin Pathol. 2011 Dec;136(6):960-9 PubMed
Nat Commun. 2013;4:2680 PubMed
Genome Res. 2011 May;21(5):790-7 PubMed
BMC Immunol. 2014 Oct 16;15:40 PubMed
Blood. 2010 Aug 19;116(7):1070-8 PubMed
PLoS One. 2008 Jul 02;3(7):e2559 PubMed
J Immunol. 2014 Mar 15;192(6):2689-98 PubMed
Genome Med. 2015 Nov 20;7:121 PubMed
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2259-64 PubMed
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5405-10 PubMed
Nature. 2015 Dec 3;528(7580):132-6 PubMed
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5348-53 PubMed
Exp Cell Res. 2014 Mar 10;322(1):12-20 PubMed
Eur J Immunol. 2012 Nov;42(11):3073-83 PubMed
Arthritis Rheumatol. 2014 Oct;66(10):2706-15 PubMed
Nat Methods. 2014 Dec;11(12):1253-60 PubMed
Blood. 2009 Nov 5;114(19):4099-107 PubMed
Clin Immunol. 2014 May-Jun;152(1-2):77-89 PubMed
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5 PubMed
Nat Rev Immunol. 2009 Mar;9(3):185-94 PubMed
Int Immunol. 2000 Jun;12(6):833-42 PubMed
Aging Cell. 2011 Dec;10(6):922-30 PubMed
J Immunol. 2002 Mar 15;168(6):3099-104 PubMed
Clin Microbiol Rev. 2000 Oct;13(4):559-70 PubMed
Nat Methods. 2014 Jun;11(6):653-5 PubMed
Immunol Rev. 2003 Dec;196:7-24 PubMed
PLoS Comput Biol. 2015 Nov 25;11(11):e1004503 PubMed
PLoS One. 2011;6(9):e25606 PubMed
EMBO Mol Med. 2011 Apr;3(4):201-7 PubMed
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2976-81 PubMed
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13463-8 PubMed
J Immunol. 2012 Sep 15;189(6):3221-30 PubMed
Clin Immunol. 2014 Mar;151(1):55-65 PubMed
PLoS One. 2012;7(11):e49774 PubMed
Nat Biotechnol. 2014 Feb;32(2):158-68 PubMed
Distinct organization of adaptive immunity in the long-lived rodent Spalax galili
Measuring Intratumoral Heterogeneity of Immune Repertoires
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons